BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 1363788)

  • 1. Regression of left ventricular hypertrophy--are there differences between antihypertensive agents?
    Dahlöf B
    Cardiology; 1992; 81(4-5):307-15. PubMed ID: 1363788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regression of left ventricular hypertrophy--a meta-analysis.
    Dahlöf B; Pennert K; Hansson L
    Clin Exp Hypertens A; 1992; 14(1-2):173-80. PubMed ID: 1347256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996).
    Schmieder RE; Schlaich MP; Klingbeil AU; Martus P
    Nephrol Dial Transplant; 1998 Mar; 13(3):564-9. PubMed ID: 9550628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of therapeutic studies on regression of left ventricular hypertrophy.
    Schmieder RE; Schlaich MP
    Adv Exp Med Biol; 1997; 432():191-8. PubMed ID: 9433526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in left ventricular geometry during antihypertensive treatment.
    Salvetti M; Paini A; Bertacchini F; Stassaldi D; Aggiusti C; Agabiti Rosei C; Bassetti D; Agabiti-Rosei E; Muiesan ML
    Pharmacol Res; 2018 Aug; 134():193-199. PubMed ID: 29959031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of combination therapy on regression of left ventricular hypertrophy in cases with hypertension.
    Boydak B; Nalbantgil S; Yilmaz H; Zoghi M; Ozerkan F; Nalbantgil I; Onder R
    Saudi Med J; 2004 Dec; 25(12):1975-8. PubMed ID: 15711679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic impact of regression of left ventricular hypertrophy by antihypertensive drugs.
    Eagle KA; Blank DJ; Aguiar E; Firth LM
    J Hum Hypertens; 1993 Aug; 7(4):341-51. PubMed ID: 8105082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Goals of antihypertensive therapy.
    McVeigh GE; Flack J; Grimm R
    Drugs; 1995 Feb; 49(2):161-75. PubMed ID: 7729325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversibility of left ventricular hypertrophy by antihypertensive drugs.
    Fagard RH
    Neth J Med; 1995 Oct; 47(4):173-9. PubMed ID: 8538821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Regression of left ventricular hypertrophy in hypertensive heart disease].
    Hennersdorf MG; Schannwell CM; Schwartzkopff B; Strauer BE
    Herz; 2003 Dec; 28(8):764-78. PubMed ID: 14689112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
    Klingbeil AU; Schneider M; Martus P; Messerli FH; Schmieder RE
    Am J Med; 2003 Jul; 115(1):41-6. PubMed ID: 12867233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agents.
    Schlaich MP; Schmieder RE
    Am J Hypertens; 1998 Nov; 11(11 Pt 1):1394-404. PubMed ID: 9832187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regression of left ventricular mass by antihypertensive treatment: a meta-analysis of randomized comparative studies.
    Fagard RH; Celis H; Thijs L; Wouters S
    Hypertension; 2009 Nov; 54(5):1084-91. PubMed ID: 19770405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyridines versus other agents in the treatment of hypertension in the elderly. Part 1: Antihypertensive therapy and left ventricular hypertrophy.
    Fagard R; Staessen J; Thijs L; Van Hoof R; Amery A
    J Hypertens Suppl; 1993 Dec; 11(6):S27-9. PubMed ID: 7909547
    [No Abstract]   [Full Text] [Related]  

  • 17. Current drug treatment and treatment patterns with antihypertensive drugs.
    Freis ED; Papademetriou V
    Drugs; 1996 Jul; 52(1):1-16. PubMed ID: 8799681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of left ventricular hypertrophy in hypertensive patients.
    Tamargo J; Delpón E; Valenzuela C
    Eur Heart J; 1993 Nov; 14 Suppl J():102-6. PubMed ID: 8281952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V; Devereux RB
    Minerva Cardioangiol; 2002 Jun; 50(3):169-74. PubMed ID: 12107398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.